Clinical Trials · NCT01789086
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 21
- Start date
- Feb 2013
- Locations
- 1 site, Germany
- Primary endpoint
- Number of treatment emergent adverse events (TEAEs)